{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T05:46:09Z","timestamp":1767073569387,"version":"3.48.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The National Key Research and Development Program of China","award":["2023YFC2505900"],"award-info":[{"award-number":["2023YFC2505900"]}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFFK0312"],"award-info":[{"award-number":["2024YFFK0312"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Surg"],"DOI":"10.1186\/s12893-025-03354-1","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T06:04:48Z","timestamp":1764309888000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Orthotopic liver transplant recipient with Enteric-coated Mycophenolate Sodium induced small bowel ulcers: two case reports"],"prefix":"10.1186","volume":"25","author":[{"given":"Shouping","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"issue":"2","key":"3354_CR1","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jhep.2015.10.006","volume":"64","author":"European Association for the Study of the Liver","year":"2016","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines: liver transplantation. J Hepatol. 2016;64(2):433\u201385. https:\/\/doi.org\/10.1016\/j.jhep.2015.10.006.","journal-title":"J Hepatol"},{"issue":"1","key":"3354_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/lt.23566","volume":"19","author":"MR Lucey","year":"2013","unstructured":"Lucey MR, Terrault N, Ojo L, et al. Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl. 2013;19(1):3\u201326. https:\/\/doi.org\/10.1002\/lt.23566.","journal-title":"Liver Transpl"},{"issue":"4","key":"3354_CR3","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1097\/TP.0b013e318205568c","volume":"91","author":"AJ Langone","year":"2011","unstructured":"Langone AJ, Chan L, Bolin P, et al. Enteric-coated mycophenolate sodium versus mycophenolate mofetil in renal transplant recipients experiencing gastrointestinal intolerance: a multicenter, double-blind, randomized study. Transplantation. 2011;91(4):470\u20138. https:\/\/doi.org\/10.1097\/TP.0b013e318205568c.","journal-title":"Transplantation"},{"key":"3354_CR4","doi-asserted-by":"publisher","unstructured":"Silva A, Madeira J, Lopes S, et al. Mycofenolate-induced Ileocolitis. Rev Esp Enferm Dig. 2024 Sep;13. https:\/\/doi.org\/10.17235\/reed.2024.10713\/2024. Online ahead of print.","DOI":"10.17235\/reed.2024.10713\/2024"},{"key":"3354_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2020.101681","volume":"46","author":"T Di Maira","year":"2020","unstructured":"Di Maira T, Little EC, Berenguer M. Immunosuppression in liver transplant. Best Pract Res Clin Gastroenterol. 2020;46:101681. https:\/\/doi.org\/10.1016\/j.bpg.2020.101681.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"7","key":"3354_CR6","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1002\/lt.20453","volume":"11","author":"RH Wiesner","year":"2005","unstructured":"Wiesner RH, Shorr JS, Steffen BJ, et al. Mycophenolate mofetil combination therapy improves long-term outcomes after liver transplantation in patients with and without hepatitis C. Liver Transpl. 2005;11(7):750\u20139. https:\/\/doi.org\/10.1002\/lt.20453.","journal-title":"Liver Transpl"},{"issue":"1","key":"3354_CR7","doi-asserted-by":"publisher","first-page":"E88","DOI":"10.1111\/j.1399-0012.2010.01339.x","volume":"25","author":"S Haywood","year":"2011","unstructured":"Haywood S, Abecassis M, Levitsky J. The renal benefit of mycophenolate mofetil after liver transplantation. Clin Transplant. 2011;25(1):E88-95. https:\/\/doi.org\/10.1111\/j.1399-0012.2010.01339.x.","journal-title":"Clin Transplant"},{"issue":"6","key":"3354_CR8","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/j.1399-0012.2008.00892.x","volume":"22","author":"S Bunnapradist","year":"2008","unstructured":"Bunnapradist S, Amb\u00fchl PM. Impact of gastrointestinal-related side effects on mycophenolate mofetil dosing and potential therapeutic strategies. Clin Transplant. 2008;22(6):815\u201321. https:\/\/doi.org\/10.1111\/j.1399-0012.2008.00892.x.","journal-title":"Clin Transplant"},{"issue":"1","key":"3354_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40360-018-0234-1","volume":"19","author":"Y Jia","year":"2018","unstructured":"Jia Y, Wang R, Li L, et al. Sites of gastrointestinal lesion induced by mycophenolate mofetil: a comparison with enteric-coated mycophenolate sodium in rats. BMC Pharmacol Toxicol. 2018;19(1):39. https:\/\/doi.org\/10.1186\/s40360-018-0234-1.","journal-title":"BMC Pharmacol Toxicol"},{"issue":"1","key":"3354_CR10","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.transproceed.2006.10.189","volume":"39","author":"W Arns","year":"2007","unstructured":"Arns W. Noninfectious gastrointestinal (GI) complications of mycophenolic acid therapy: a consequence of local GI toxicity? Transplant Proc. 2007;39(1):88\u201393. https:\/\/doi.org\/10.1016\/j.transproceed.2006.10.189.","journal-title":"Transplant Proc"},{"issue":"5","key":"3354_CR11","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1097\/01.TP.0000053753.43268.F0","volume":"75","author":"BD Maes","year":"2003","unstructured":"Maes BD, Dalle I, Geboes K, et al. Erosive enterocolitis in mycophenolate mofetil-treated renal-transplant recipients with persistent afebrile diarrhea. Transplantation. 2003;75(5):665\u201372. https:\/\/doi.org\/10.1097\/01.TP.0000053753.43268.F0.","journal-title":"Transplantation"},{"issue":"9","key":"3354_CR12","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1097\/pas.0b013e31816bf3fe","volume":"32","author":"JR Parfitt","year":"2008","unstructured":"Parfitt JR, Jayakumar S, Driman DK. Mycophenolate mofetil-related gastrointestinal mucosal injury: variable injury patterns, including graft-versus-host disease-like changes. Am J Surg Pathol. 2008;32(9):1367\u201372. https:\/\/doi.org\/10.1097\/pas.0b013e31816bf3fe.","journal-title":"Am J Surg Pathol"},{"key":"3354_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2022.101554","volume":"71","author":"F \u00c7\u0131nar","year":"2022","unstructured":"\u00c7\u0131nar F, Bulbuloglu S. The effect of adherence to immunosuppressant therapy on gastrointestinal complications after liver transplantation. Transpl Immunol. 2022;71:101554. https:\/\/doi.org\/10.1016\/j.trim.2022.101554.","journal-title":"Transpl Immunol"},{"issue":"11","key":"3354_CR14","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1345\/aph.1D063","volume":"37","author":"S Gabardi","year":"2003","unstructured":"Gabardi S, Tran JL, Clarkson MR. Enteric-coated mycophenolate sodium. Ann Pharmacother. 2003;37(11):1685\u201393. https:\/\/doi.org\/10.1345\/aph.1D063.","journal-title":"Ann Pharmacother"},{"issue":"10","key":"3354_CR15","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1007\/s10620-020-06573-z","volume":"65","author":"A Abbass","year":"2020","unstructured":"Abbass A, Khalid S, Boppana V, et al. Giant gastric ulcers: an unusual culprit. Dig Dis Sci. 2020;65(10):2811\u20137. https:\/\/doi.org\/10.1007\/s10620-020-06573-z.","journal-title":"Dig Dis Sci"},{"issue":"4","key":"3354_CR16","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s40268-018-0254-8","volume":"18","author":"KM Gardiner","year":"2018","unstructured":"Gardiner KM, Tett SE, Staatz CE. Is conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium justifiable for gastrointestinal quality of life? Drugs R D. 2018;18(4):271\u201382. https:\/\/doi.org\/10.1007\/s40268-018-0254-8.","journal-title":"Drugs R D"},{"key":"3354_CR17","doi-asserted-by":"publisher","first-page":"e920235","DOI":"10.12659\/AJCR.920235","volume":"21","author":"CC Morris","year":"2020","unstructured":"Morris CC, Stroud SC, Golconda U, et al. Orthotopic heart transplant recipient with enteric-coated mycophenolate sodium (Myfortic) induced colitis. Am J Case Rep. 2020;21:e920235. https:\/\/doi.org\/10.12659\/AJCR.920235.","journal-title":"Am J Case Rep"},{"issue":"15","key":"3354_CR18","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.2169\/internalmedicine.55.5968","volume":"55","author":"H Liu","year":"2016","unstructured":"Liu H, Wang Y, Fan B, et al. Improvement in severe mycophenolic acid-associated gastrointestinal symptoms after changing enteric-coated mycophenolate sodium to mizoribine in renal transplant recipients: two case reports. Intern Med. 2016;55(15):2005\u201310. https:\/\/doi.org\/10.2169\/internalmedicine.55.5968.","journal-title":"Intern Med"},{"issue":"9","key":"3354_CR19","doi-asserted-by":"publisher","first-page":"645","DOI":"10.2165\/00002018-200124090-00002","volume":"24","author":"M Behrend","year":"2001","unstructured":"Behrend M. Adverse gastrointestinal effects of mycophenolate mofetil: aetiology, incidence and management. Drug Saf. 2001;24(9):645\u201363. https:\/\/doi.org\/10.2165\/00002018-200124090-00002.","journal-title":"Drug Saf"},{"key":"3354_CR20","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/S0021-9258(19)83755-9","volume":"237","author":"DW Wilson","year":"1962","unstructured":"Wilson DW, Wilson HC. Studies in vitro of the digestion and absorption of purine ribonucleotides by the intestine. J Biol Chem. 1962;237:1643\u20137.","journal-title":"J Biol Chem"},{"issue":"1","key":"3354_CR21","doi-asserted-by":"publisher","first-page":"E47","DOI":"10.1152\/ajpendo.1977.233.1.E47","volume":"233","author":"V Harms","year":"1977","unstructured":"Harms V, Stirling CE. Transport of purine nucleotides and nucleosides by in vitro rabbit ileum. Am J Physiol. 1977;233(1):E47\u201355. https:\/\/doi.org\/10.1152\/ajpendo.1977.233.1.E47.","journal-title":"Am J Physiol"},{"issue":"5","key":"3354_CR22","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1139\/y77-142","volume":"55","author":"N Kolassa","year":"1977","unstructured":"Kolassa N, Stengg R, Turnheim K. Adenosine uptake by the isolated epit","journal-title":"Can J Physiol Pharmacol"}],"container-title":["BMC Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-025-03354-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12893-025-03354-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-025-03354-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T05:43:37Z","timestamp":1767073417000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12893-025-03354-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3354"],"URL":"https:\/\/doi.org\/10.1186\/s12893-025-03354-1","relation":{},"ISSN":["1471-2482"],"issn-type":[{"type":"electronic","value":"1471-2482"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"14 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Clinical trial number: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We have obtained written informed consent from the patient for the publication of the report and accompanying images. And all authors agreed to publish.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"616"}}